Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Zillow Group Inc Class A (ZG) vs Zoetis Inc (ZTS) Price & Performance

Zillow Group Inc Class ATrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Zillow Group Inc Class A vs Zoetis Inc — how do they compare? Zillow Group Inc Class A trades at $34.4 (market cap $7.68B), while Zoetis Inc trades at $73.72 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 4.1× Zillow Group Inc Class A's market cap, and Zoetis Inc pays a 2.81% dividend while Zillow Group Inc Class A pays none. Which is the better fit depends on your goals.

ZGZTS
Market Cap
$7.68B$31.14B
Sector
MediaHealth
52-Week High
$86.76$156.76
52-Week Low
$29.14$71.91
Enterprise Value
$7.56B$38.70B
Dividend Yield
2.81%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Zillow Group Inc Class A

Zillow Group (ZG) trades at $33.46, down 1.81% with a bearish technical signal. The company shows improving fundamentals with Q2 2026 earnings beats and 18% revenue growth, though net margins remain thin at 1.96%. Recent news highlights strong performance in the preferred agent model but is overshadowed by multiple securities class action lawsuits with August 2026 deadlines. Valuation metrics appear elevated with a P/E of 149, while analyst consensus targets $47.56 with mixed ratings.

The outlook is cautiously optimistic given ZG's business model transition and revenue growth, but significant legal overhangs and high valuation create near-term risks. Long-term potential exists if monetization improvements continue, though investors should weigh legal uncertainties against fundamental progress.

Zoetis Inc

Zoetis (ZTS) trades at $73.4, down 1.95% on the day, as technical indicators signal a bearish trend amid recent price weakness. Fundamentally, the company reported Q2 2026 EPS of $1.87, beating estimates, but revenue was flat and full-year guidance was cut due to softer pet healthcare demand. Analyst sentiment remains mixed with a consensus price target of $94.90, though recent news highlights competitive pressures and a securities class action lawsuit.

The stock presents a value opportunity given its attractive P/E of 12.29 and strong profitability margins, but near-term headwinds from U.S. companion-animal market challenges and legal overhangs pose risks. Upside depends on execution against revised 2026 targets and stabilization in core markets.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Zillow Group Inc Class A

Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.

Read more on ZG

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS